Bibliotecas PUC-SP - Busca Integrada

Recent advances in understanding colorectal cancer [version 1; referees: 2 approved]

Por Sebastian Stintzing
Publicado no F1000Research (2018-09-01)

Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future

Por Matthias Ocker, Christian Mayr, Tobias Kiesslich, Sebastian Stintzing, Daniel Neureiter
Publicado no Cancers (2021-03-01)

Patient Selection Approaches in FGFR Inhibitor Trials—Many Paths to the Same End?

Por Peter Ellinghaus, Daniel Neureiter, Hendrik Nogai, Sebastian Stintzing, Matthias Ocker
Publicado no Cells (2022-10-01)

ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer

Por George Pentheroudakis, Loredana Vecchione, Jean-Yves Douillard, Florian Lordick, Sebastian Stintzing
Publicado no ESMO Open (2020-11-01)

Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?

Por Sebastian Stintzing, Ralf Kemmerling, Tobias Kiesslich, Beate Alinger, Matthias Ocker, Daniel Neureiter
Publicado no Journal of Biomedicine and Biotechnology (2011-01-01)

Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer

Por Chiara Cremolini, Clara Montagut, Philippe Ronga, Filippo Venturini, Kensei Yamaguchi, Sebastian Stintzing, Alberto Sobrero
Publicado no Frontiers in Oncology (2023-02-01)

Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation

Por Dino Bekric, Matthias Ocker, Christian Mayr, Sebastian Stintzing, Markus Ritter, Tobias Kiesslich, Daniel Neureiter
Publicado no Cancers (2022-04-01)

Survey of Long-Term Experiences of Sperm Cryopreservation in Oncological and Non-Oncological Patients: Usage and Reproductive Outcomes of a Large Monocentric Cohort

Por Nadine Lackamp, Ina Wilkemeyer, Ivan Jelas, Ulrich Keller, Lars Bullinger, Sebastian Stintzing, Philipp le Coutre
Publicado no Frontiers in Oncology (2021-11-01)

Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors

Por Jesús García-Foncillas, Yu Sunakawa, Dan Aderka, Zev Wainberg, Philippe Ronga, Pauline Witzler, Sebastian Stintzing
Publicado no Frontiers in Oncology (2019-09-01)

PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 Inhibition

Por Luise Victoria Claaß, Christoph Schultheiß, Rebekka Scholz, Lisa Paschold, Donjete Simnica, Volker Heinemann, Sebastian Stintzing, Mascha Binder
Publicado no Frontiers in Oncology (2022-07-01)

Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures

Por Abdelhadi Boulifa, Martin J. Raftery, Alexander Sebastian Franzén, Clarissa Radecke, Sebastian Stintzing, Jens-Uwe Blohmer, Gabriele Pecher
Publicado no BMC Cancer (2024-03-01)

Long‐term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controls

Por Nina Winkelmann, Michaela Schwarz, Bert Hildebrandt, Oliver Henke, Lars Bullinger, Il‐Kang Na, Sebastian Stintzing, Philipp le Coutre
Publicado no eJHaem (2022-08-01)

Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer

Por Martin J. Raftery, Alexander Sebastian Franzén, Clarissa Radecke, Abdelhadi Boulifa, Günther Schönrich, Sebastian Stintzing, Jens-Uwe Blohmer, Gabriele Pecher
Publicado no International Journal of Molecular Sciences (2023-05-01)

Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients—A Single Center Analysis of 2323 Patients within the Last De...

Por Christopher C. M. Neumann, François Schneider, Georg Hilfenhaus, Loredana Vecchione, Christian Benzing, Jana Ihlow, Uli Fehrenbach, Thomas Malinka, Ulrich Keilholz, Sebastian Stintzing, Uwe Pelzer
Publicado no Journal of Clinical Medicine (2023-05-01)

Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinom...

Por Beate Schultheis, Dirk Strumberg, Jan Kuhlmann, Martin Wolf, Karin Link, Thomas Seufferlein, Joerg Kaufmann, Mathilde Feist, Frank Gebhardt, Mike Khan, Sebastian Stintzing, Uwe Pelzer
Publicado no Cancers (2020-10-01)

Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients—Analysis of...

Por Sebastian Stintzing, Boryana Ivanova, Boryana Ivanova, Ingrid Ricard, Andreas Jung, Thomas Kirchner, Andrea Tannapfel, Hendrik Juette, Susanna Hegewisch-Becker, Dirk Arnold, Anke Reinacher-Schick
Publicado no Frontiers in Oncology (2018-11-01)

EMT-Related Genes Have No Prognostic Relevance in Metastatic Colorectal Cancer as Opposed to Stage II/III: Analysis of the Randomised, Phase III Trial FIRE-3 (AIO KRK 0306; FIRE-3)

Por Elise Pretzsch, Volker Heinemann, Sebastian Stintzing, Andreas Bender, Shuo Chen, Julian Walter Holch, Felix Oliver Hofmann, Haoyu Ren, Florian Bösch, Helmut Küchenhoff, Jens Werner, Martin Konrad Angele
Publicado no Cancers (2022-11-01)

Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer—The CONKO-008 Phase I Investigation

Por Jana K. Striefler, Jens M. Stieler, Christopher C. M. Neumann, Dominik Geisel, Pirus Ghadjar, Marianne Sinn, Thomas Malinka, Johann Pratschke, Sebastian Stintzing, Helmut Oettle, Hanno Riess, Uwe Pelzer
Publicado no Journal of Clinical Medicine (2022-08-01)

Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study

Por Jana Käthe Striefler, Hanno Riess, Philipp Lohneis, Sven Bischoff, Annika Kurreck, Dominik Paul Modest, Marcus Bahra, Helmut Oettle, Marianne Sinn, Henrik Bläker, Carsten Denkert, Sebastian Stintzing, Bruno Valentin Sinn, Uwe Pelzer
Publicado no Frontiers in Oncology (2021-07-01)

Liquid Biopsy in Colorectal Cancer: Quo Vadis? Implementation of Liquid Biopsies in Routine Clinical Patient Care in Two German Comprehensive Cancer Centers

Por Laura E. Fischer, Laura E. Fischer, Sebastian Stintzing, Sebastian Stintzing, Volker Heinemann, Volker Heinemann, Volker Heinemann, Ulrich Keilholz, Ulrich Keilholz, Dietmar Keune, Claudia Vollbrecht, Thomas Burmeister, Thomas Burmeister, Andreas Kind, Lena Weiss, David Horst, David Horst, Thomas Kirchner, Thomas Kirchner, Thomas Kirchner, Frederick Klauschen, Frederick Klauschen, Frederick Klauschen, Frederick Klauschen, Andreas Jung, Andreas Jung, Andreas Jung, Christoph Benedikt Westphalen, Christoph Benedikt Westphalen, Christoph Benedikt Westphalen, Ivan Jelas, Ivan Jelas
Publicado no Frontiers in Oncology (2022-05-01)